Dermal Pathology in Melasma: An Update Review
Issued Date
2022-01-01
Resource Type
eISSN
11787015
Scopus ID
2-s2.0-85123862105
Journal Title
Clinical, Cosmetic and Investigational Dermatology
Volume
15
Start Page
11
End Page
19
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical, Cosmetic and Investigational Dermatology Vol.15 (2022) , 11-19
Suggested Citation
Phansuk K. Dermal Pathology in Melasma: An Update Review. Clinical, Cosmetic and Investigational Dermatology Vol.15 (2022) , 11-19. 19. doi:10.2147/CCID.S343332 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/86676
Title
Dermal Pathology in Melasma: An Update Review
Author(s)
Author's Affiliation
Other Contributor(s)
Abstract
Background: Melasma is a complex and multipathophysiological condition that is challenging to treat. The roles of each element in the dermis were highlighted in this recent year due to targeting it with emerging therapies. Although some studies have demonstrated abnormal findings in the dermis of melasma lesions, there are no integrated data regarding these findings. Purpose: This article aims to discuss each finding in the dermis of melasma lesions and to provide some ideas about treatment options. Methods: An Internet search was completed using the MEDLINE, Embase, Scopus, and Google Scholar databases for relevant literature through June 2021 and reference lists of respective articles. Only the articles published in English language were included. Results: Several studies have focused on the dermal changes in melasma. Common findings included basement membrane disruption, pendulous melanocytes, marked solar elastosis, increased melanophages, increased mast cells, and neovascularization. In addition, each of them had the specified mechanism that may relate with the others. Conclusion: Several changes in the dermis of melasma lesion may be connected with pathological changes in the epidermis. This may serve as a potential target treatment for melasma, which requires a multimodal approach.